Andreas Jensen

647 total citations
31 papers, 452 citations indexed

About

Andreas Jensen is a scholar working on Epidemiology, Immunology and Health. According to data from OpenAlex, Andreas Jensen has authored 31 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 8 papers in Immunology and 7 papers in Health. Recurrent topics in Andreas Jensen's work include Vaccine Coverage and Hesitancy (7 papers), Respiratory viral infections research (6 papers) and Pneumonia and Respiratory Infections (6 papers). Andreas Jensen is often cited by papers focused on Vaccine Coverage and Hesitancy (7 papers), Respiratory viral infections research (6 papers) and Pneumonia and Respiratory Infections (6 papers). Andreas Jensen collaborates with scholars based in Denmark, United States and United Kingdom. Andreas Jensen's co-authors include B Friis, A Hornsleth, Lone Graff Stensballe, Troels Vinding, E Gregersen, Brita Bruun, Carl H. Mordhorst, Steen Ethelberg, Jørgen Engberg and C. Jensen and has published in prestigious journals such as PLoS ONE, Journal of Virology and European Heart Journal.

In The Last Decade

Andreas Jensen

23 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Jensen Denmark 9 257 100 74 65 47 31 452
M C Fariñas Spain 13 195 0.8× 56 0.6× 16 0.2× 20 0.3× 264 5.6× 21 545
M.W.M. Wassenberg Netherlands 14 81 0.3× 47 0.5× 14 0.2× 20 0.3× 326 6.9× 18 598
J. Richards United Kingdom 8 135 0.5× 63 0.6× 6 0.1× 11 0.2× 90 1.9× 13 422
Torsten T. Bauer Germany 14 179 0.7× 228 2.3× 6 0.1× 12 0.2× 53 1.1× 37 629
H J Odendaal South Africa 16 136 0.5× 76 0.8× 12 0.2× 146 2.2× 46 1.0× 60 742
Ashlesha Kaushik United States 11 71 0.3× 75 0.8× 6 0.1× 17 0.3× 188 4.0× 33 568
Yassuhiko Okay Brazil 12 132 0.5× 93 0.9× 4 0.1× 13 0.2× 109 2.3× 62 430
Nitin Bhanot United States 13 140 0.5× 55 0.6× 2 0.0× 24 0.4× 292 6.2× 57 605
Yamikani Chimalizeni Malawi 9 94 0.4× 5 0.1× 5 0.1× 30 0.5× 65 1.4× 23 455
S. K. Kabra India 13 143 0.6× 152 1.5× 5 0.1× 5 0.1× 112 2.4× 37 484

Countries citing papers authored by Andreas Jensen

Since Specialization
Citations

This map shows the geographic impact of Andreas Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Jensen more than expected).

Fields of papers citing papers by Andreas Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Jensen. The network helps show where Andreas Jensen may publish in the future.

Co-authorship network of co-authors of Andreas Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Jensen. A scholar is included among the top collaborators of Andreas Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Jensen. Andreas Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Jensen, Andreas, et al.. (2025). Measles vaccines and non-specific effects on mortality or morbidity: A systematic review and meta-analysis. PLoS ONE. 20(7). e0321982–e0321982. 2 indexed citations
4.
Jensen, Andreas & Lone Graff Stensballe. (2025). Impact of COVID-19 on testing, positive cases, patient characteristics, and hospital contacts for respiratory syncytial virus, influenza, and pneumococcus in Danish children. Journal of Infection and Public Health. 18(2). 102660–102660. 2 indexed citations
5.
6.
Klausen, Mette Kruse, Line Jee Hartmann Rasmussen, Marchen Hviid, et al.. (2025). Semaglutide and Early-Stage Metabolic Abnormalities in Individuals With Schizophrenia Spectrum Disorders. JAMA Psychiatry. 83(2). 128–128.
7.
8.
9.
Jensen, Andreas, Eric A. F. Simões, Nikolai Kirkby, et al.. (2024). Immunogenicity and reactogenicity following MMR vaccination in 5–7-month-old infants: a double-blind placebo-controlled randomized clinical trial in 6540 Danish infants. EClinicalMedicine. 68. 102421–102421. 5 indexed citations
10.
Jensen, Andreas, et al.. (2024). Post‐Marketing Safety of Ustekinumab Based on 14‐Year Follow‐Up in Danish National Patient Data. Pharmacoepidemiology and Drug Safety. 33(12). e70064–e70064. 1 indexed citations
11.
12.
13.
Jensen, Andreas, Gorm Greisen, & Lone Graff Stensballe. (2022). Socioeconomic background affects mortality in Danish children with severe chronic disease. Acta Paediatrica. 111(12). 2393–2399. 3 indexed citations
14.
Jensen, Andreas, et al.. (2021). Respiratory syncytial virus and influenza hospitalizations in Danish children 2010–2016. Vaccine. 39(30). 4126–4134. 11 indexed citations
15.
Jensen, Andreas, Per Kragh Andersen, John Sahl Andersen, Gorm Greisen, & Lone Graff Stensballe. (2020). The match between need and use of health services among healthy under-fives in Denmark: A register-based national cohort study. PLoS ONE. 15(4). e0231776–e0231776.
16.
Jensen, Andreas, Per Kragh Andersen, John Sahl Andersen, Gorm Greisen, & Lone Graff Stensballe. (2019). Risk factors of post-discharge under-five mortality among Danish children 1997-2016: A register-based study. PLoS ONE. 14(12). e0226045–e0226045. 6 indexed citations
17.
Jensen, Andreas, Per Kragh Andersen, & Lone Graff Stensballe. (2019). Early childhood vaccination and subsequent mortality or morbidity: are observational studies hampered by residual confounding? A Danish register-based cohort study. BMJ Open. 9(9). e029794–e029794. 14 indexed citations
18.
Stensballe, Lone Graff, et al.. (2017). The validity of register data to identify children with atopic dermatitis, asthma or allergic rhinoconjunctivitis. Pediatric Allergy and Immunology. 28(6). 535–542. 33 indexed citations
19.
Gerner‐Smidt, Peter, Steen Ethelberg, Peter Schiellerup, et al.. (2005). Invasive listeriosis in Denmark 1994–2003: a review of 299 cases with special emphasis on risk factors for mortality. Clinical Microbiology and Infection. 11(8). 618–624. 89 indexed citations
20.
Vinding, Troels, et al.. (1991). Prevalence of amblyopia in old people without previous screening and treatment. Acta Ophthalmologica. 69(6). 796–798. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M C Fariñas Breakdown of academic impact, for papers by M.W.M. Wassenberg Breakdown of academic impact, for papers by J. Richards Breakdown of academic impact, for papers by Torsten T. Bauer Breakdown of academic impact, for papers by H J Odendaal Breakdown of academic impact, for papers by Ashlesha Kaushik Breakdown of academic impact, for papers by Yassuhiko Okay Breakdown of academic impact, for papers by Nitin Bhanot Breakdown of academic impact, for papers by Yamikani Chimalizeni Breakdown of academic impact, for papers by S. K. Kabra
Rankless by CCL
2026